
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
[ Tue, Oct 04th 2022 ]: WOPRAI
Nick Abbott Maintained (ADAP) at Hold with Decreased Target to $1.5 on, Oct 4th, 2022


🞛 This publication is a summary or evaluation of another publication
Nick Abbott of Wells Fargo, Maintained "Adaptimmune Therapeutics plc" (ADAP) at Hold with Decreased Target from $7 to $1.5 on, Oct 4th, 2022.
Nick, nor any peers, have made any analyst calls on ADAP in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30